SPINALON (buspirone + levodopa + cardidopa)
SPIN-01
Phase 2 small_molecule completed
Quick answer
SPINALON (buspirone + levodopa + cardidopa) for Spinal Cord Injury is a Phase 2 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Spinal Cord Injury
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed